APL 2301
Alternative Names: APL-2301; ASN-1733; MET-102Latest Information Update: 27 Dec 2023
At a glance
- Originator Asieris Pharmaceuticals
- Class Anti-infectives; Antibacterials; Small molecules
- Mechanism of Action Bacterial growth inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Acinetobacter infections